# The Digital Diabetes Patient Reminder (DIPAR) Tool For Adults With Type 2 Diabetes

Study · id `cardio:ct-nct07257822` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07257822](<https://clinicaltrials.gov/study/NCT07257822>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT07257822

Browse, organ or system: Metabolism  
Browse, condition area: Diabetes and metabolic disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 200 participants.

## Technical summary

Registry record NCT07257822. Randomized; single masking; primary purpose supportive care. Start 2025-10-06 (actual); primary completion 2027-06 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose supportive care
- Phase: Not applicable
- Enrolled: 200 participants (planned count; ClinicalTrials.gov record NCT07257822, source copy `cardio:ctgov-nct07257822-2026-02-19`, retrieved 2026-10-26)
- Started: 2025-10-06 (actual) (ClinicalTrials.gov record NCT07257822, source copy `cardio:ctgov-nct07257822-2026-02-19`, retrieved 2026-10-26)
- Primary completion: 2027-06 (anticipated) (ClinicalTrials.gov record NCT07257822, source copy `cardio:ctgov-nct07257822-2026-02-19`, retrieved 2026-10-26)
- Completion: 2027-06 (anticipated) (ClinicalTrials.gov record NCT07257822, source copy `cardio:ctgov-nct07257822-2026-02-19`, retrieved 2026-10-26)
- Countries: Belgium (ClinicalTrials.gov record NCT07257822, source copy `cardio:ctgov-nct07257822-2026-02-19`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "ACTIVE\_NOT\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07257822-2026-02-19`, retrieved 2026-10-26)

## The registry's words

- Brief title: The Digital Diabetes Patient Reminder (DIPAR) Tool For Adults With Type 2 Diabetes
- Acronym: DIPAR RCT
- Condition: Type 2 Diabetes Mellitus (T2DM)
- Intervention (Device): Digital Diabetes Patient Reminder Tool
- Intervention (Other): Standard of Care treatment and follow-up
- Lead sponsor: KU Leuven
- Lead sponsor class: OTHER
- Collaborator: Regionaal Ziekenhuis Heilig Hart Tienen
- Collaborator class: OTHER
- Collaborator: Universitaire Ziekenhuizen KU Leuven
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Type 2 diabetes (`cardio:type-2-diabetes`)
- Registry lists this organization as the lead sponsor: KU Leuven (`cardio:org-ku-leuven`)
- Registry lists this organization as a collaborator: Universitaire Ziekenhuizen KU Leuven (`cardio:org-universitaire-ziekenhuizen-ku-leuven`)

## Provenance

Content hash: f303ba7e9aa73abcc542338734738a4361bfaeb4715840b2b14f58481c7d98d0
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
